The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ia dose escalation of IBI318, a first-in-class bispecific anti-PD-1/PD-L1, in patients with advanced tumors.
 
Rui-hua Xu
No Relationships to Disclose
 
Hongyun Zhao
No Relationships to Disclose
 
Xiao-Li Wei
No Relationships to Disclose
 
Yang Zhang
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Fenghua Wang
No Relationships to Disclose
 
Yu-Hong Li
No Relationships to Disclose
 
Ben-Yan Zou
No Relationships to Disclose
 
Xiaomin Zhu
Employment - Innovent Biologics
 
Wencheng Yu
Employment - Innovent Biologics
 
Hui Zhou
Employment - Innovent Biologics